id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0242-0022,FDA,FDA-2013-N-0242,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practices for Positron Emission Tomography Drugs,Notice,30 Day Proposed Information Collection,2022-10-07T04:00:00Z,2022,10,2022-10-07T04:00:00Z,,2022-10-07T16:50:57Z,2022-21842,0,0,09000064853d4562
FDA-2013-N-0242-0016,FDA,FDA-2013-N-0242,"Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good
Manufacturing Practices for Positron Emission Tomography Drugs",Notice,60 Day Proposed Information Collection,2022-04-07T04:00:00Z,2022,4,2022-04-07T04:00:00Z,2022-06-07T03:59:59Z,2022-10-07T16:50:03Z,2022-07392,0,0,0900006484fff3ed
FDA-2013-N-0242-0015,FDA,FDA-2013-N-0242,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2019-12-31T05:00:00Z,2019,12,2019-12-31T05:00:00Z,,2019-12-31T14:54:02Z,2019-28249,0,0,090000648425db8d
FDA-2013-N-0242-0014,FDA,FDA-2013-N-0242,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Current Good
Manufacturing Practices for Positron Emission Tomography Drugs",Notice,30 Day Proposed Information Collection,2019-09-04T04:00:00Z,2019,9,2019-09-04T04:00:00Z,2019-10-05T03:59:59Z,2019-09-04T13:38:46Z,2019-19030,0,0,0900006483ee78af
FDA-2013-N-0242-0010,FDA,FDA-2013-N-0242,Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practices for Positron Emission Tomography Drugs,Notice,60 Day Proposed Information Collection,2019-03-14T04:00:00Z,2019,3,2019-03-14T04:00:00Z,2019-05-14T03:59:59Z,2019-07-30T11:13:58Z,2019-04716,0,0,0900006483adea28
FDA-2013-N-0242-0009,FDA,FDA-2013-N-0242,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Announcement of Office of Management and Budget Approvals",Notice,Notice of Approval,2016-12-19T05:00:00Z,2016,12,2016-12-19T05:00:00Z,,2016-12-19T15:46:13Z,2016-30351,0,0,09000064824264d1
FDA-2013-N-0242-0008,FDA,FDA-2013-N-0242,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice for Positron Emission Tomography Drugs,Notice,30 Day Proposed Information Collection,2016-07-11T04:00:00Z,2016,7,2016-07-11T04:00:00Z,2016-08-11T03:59:59Z,2016-07-11T15:30:51Z,2016-16360,0,0,090000648209bdc7
FDA-2013-N-0242-0005,FDA,FDA-2013-N-0242,Agency Information Collection Activities: Proposed Collection; Comment Request; Current Good Manufacturing Practice for Positron Emission Tomography Drugs,Notice,60 Day Proposed Information Collection,2015-12-29T05:00:00Z,2015,12,2015-12-29T05:00:00Z,2016-03-01T04:59:59Z,2016-02-29T22:00:25Z,2015-32685,0,0,0900006481dd7930
FDA-2013-N-0242-0004,FDA,FDA-2013-N-0242,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Current Good Manufacturing Practice for Positron Emission Tomography Drugs",Notice,General Notice,2013-07-18T04:00:00Z,2013,7,2013-07-18T04:00:00Z,,2015-12-21T17:11:37Z,2013-17213,0,0,090000648136d4cb
FDA-2013-N-0242-0001,FDA,FDA-2013-N-0242,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Current Good Manufacturing Practice for Positron Emission Tomography Drugs",Notice,60 Day Proposed Information Collection,2013-03-20T04:00:00Z,2013,3,2013-03-20T04:00:00Z,2013-05-21T03:59:59Z,2015-12-21T17:10:36Z,2013-06351,0,0,09000064812374da